Status: Recruiting
Neonatal Platelet Transfusion Threshold Trial
The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
Participants needed: 2,433
Trial details
Age: 1-48Biological sex: AllType: InterventionalSponsor: NICHD Neonatal Research NetworkUpdated: Mar 25, 2026Locations: 20
Eligibility criteria
Gestational age of 23 0/7 to 26 6/7 weeks [+1]
Comfort care or withdrawal of care planned [+4]